Problem

Healthcare providers lose patients and staff time to overloaded phone lines, missed calls, long holds, and repetitive administrative work. Confido’s own framing is that “every missed call is missed patient care,” while phone overload pulls staff away from patients already in the office. The economics are operational and financial: front-desk capacity is consumed by routine calls, unresolved requests can leak patients and revenue, and administrative staffing shortages make adding human capacity expensive. The killer use case is the high-volume inbound patient call—especially scheduling, rescheduling, cancellations, and follow-up—where less than half of patient calls are reportedly resolved on the first attempt.

Product / Service

Confido Health sells AI-powered healthcare communication and workflow automation as an operational layer between patient channels, phone systems, and the provider’s EHR or practice-management system. Its assistants answer calls on existing lines, conduct the interaction, perform the requested task, and write the outcome back into the system of record. Appointment workflows include booking, rescheduling, cancellation, confirmation, and waitlist backfilling; the platform also supports insurance verification, prior authorization, payments, referrals, refills, denial management, and patient reactivation.

The benefit is not merely call deflection but end-to-end task completion: providers get round-the-clock access, fewer missed calls and holds, and more staff time for in-person care. Confido reports 40-plus live integrations across EHR, PMS, and telephony systems, and a customer example describes 20,000 weekly calls across 51 locations with 40% handled automatically.

Market

Confido competes in healthcare AI, specifically patient-access voice AI and broader front-, mid-, and back-office workflow automation. The category includes patient access, revenue-cycle, clinical documentation, and other healthcare operations software; Confido positions itself toward end-to-end execution inside healthcare systems rather than a standalone chatbot or call router. Named adjacent competitors include Hyro, which focuses on high-volume questions and intelligent routing, and Notable Health, which automates patient access and administrative workflows for enterprise health systems. Other alternatives in the broader voice-AI market include Assort Health and EliseAI.

The company appears to be commercial and in active expansion rather than pre-revenue: it has live provider customers, reported round-the-clock access for more than 1 million patients by September 2025, and agents deployed across specialties including pediatrics, orthopedics, GI, nephrology, dermatology, and pain medicine. It raised a $10 million Series A in September 2025, bringing total disclosed funding to $13 million. Revenue is not disclosed in the available research, so the strongest evidence of traction is deployment scale, customer usage, automation rates, and funding rather than reported sales.